← Eichor
Study identifier: NCT06080074 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Condition: Heart Failure · Cardiogenic Shock · Congenital Heart Disease  ·  Sponsor: Stanford University

PhasePhase 2
Planned participants50
Who can joinAll sexes, 0 Years to 16 Years
Healthy volunteersNo

About this study

There are two primary goals of this multicenter clinical trial that combines an FDA device trial and a phase II drug trial in the same study cohort. These two goals are to: 1. To evaluate the safety and effectiveness of the Cardiohelp Device for VA-ECMO (heart-lung support) for up to 30 days of support in children with severe heart failure with the goal to support its FDA clearance in children. 2. To evaluate heparin versus bivalirudin as the primary blood thinner (anticoagulant) in a randomized trial of children supported with the Cardiohelp ECMO System with the goal to plan a phase III (pivotal) randomized clinical trial The main questions the Cardiohelp single-arm trial seeks to answer are: * What is the safety and effectiveness of the Cardiohelp device for pediatric ECMO? * Should the Cardiohelp device be FDA-cleared for children based on the results of the study? * What are the optimal performance specifications of the Cardiohelp device in children? The main questions the blood thinner randomized trial seeks to answer are: * Which blood thinner is more promising (i.e., more effective and safer) in children on the Cardiohelp device? * How should a pivotal trial of heparin vs. bivalirudin be designed so it is the most informative and efficient to determine the best blood thinner? Children who are receiving the Cardiohelp device will be approached and consented to participate if interested. For the Cardiohelp device trial, participants will undergo a standardized data…

This description comes directly from the study's public registry record.

Talk to the study team

Christopher SD Almond, MD, MPH  ·  6507237913  ·  calmond@stanford.edu

Selena Gonzales, MPH  ·  650-723-7913  ·  selena.gonzales@stanford.edu

Always discuss trial participation with your own doctor first.

Locations (5)

Lucile Packard Children's HospitalPalo Alto, California, United StatesRecruiting
Cuimc/NyphNew York, New York, United StatesRecruiting
Duke University HospitalDurham, North Carolina, United StatesRecruiting
Children's Health DallasDallas, Texas, United StatesRecruiting
Seattle Children's HospitalSeattle, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06080074